Fourth Question of the Day July 4, 2014 The letter sent by 31 members of Congress to the FDA urges the FDA to protect patient safety by ensuring that doctors have a safe source of drugs provided through the practice of pharmacy when manufactured products are unavailable or do not fit a patient’s needs Does an outsourcing facility that is inspected by the FDA provide doctors with a safe source of drugs when manufactured drugs are not available or do not fit a patient's needs?

Members of Congress Seek Clarity from FDA Regarding Compounding Law Implementation:  On Friday, 31 members of congress sent a letter to FDA seeking to clarify the intent of FDA to regulate office use compounding as well as to voice their support for the repackaging of finished FDA approved drugs.  Representatives Morgan Griffith (R-Va.), Gene Green (D-Tx.) and Diana DeGette (D-Co.) led the bipartisan letter, and NCPA strongly supports this letter as it stresses the importance of allowing traditional pharmacies to continue to be allowed to compound small amounts of medications for office use.  The letter urges the FDA to protect patient safety by ensuring that doctors have a safe source of drugs provided through the practice of pharmacy when manufactured products are unavailable or do not fit a patient’s needs

quoted from here